previous
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00301 | 1 | CBU_0983 | 291 | March 2008 | 2D8D | 10% | Coxiella burnetii | |||||||||||||||||||||||
| IDP90097 | 8 | ZZZ_0013 | 104 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90094 | 8 | ZZZ_0010 | 358 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90095 | 8 | ZZZ_0011 | 184 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90088 | 8 | ZZZ_0004 | 140 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90087 | 8 | ZZZ_0003 | 168 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90093 | 8 | ZZZ_0009 | 99 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90086 | 8 | ZZZ_0002 | 492 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90092 | 8 | ZZZ_0008 | 155 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90100 | 8 | ZZZ_0016 | 849 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | 1QVR | 37.1% | Escherichia coli | ||||||||||||||||||||||
| IDP90090 | 8 | ZZZ_0006 | 310 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90096 | 8 | ZZZ_0012 | 476 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90091 | 8 | ZZZ_0007 | 660 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | 2P5Z | 15.6% | Escherichia coli | ||||||||||||||||||||||
| IDP90099 | 8 | ZZZ_0015 | 1137 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90098 | 8 | ZZZ_0014 | 196 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90085 | 8 | ZZZ_0001 | 158 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP00300 | 1 | CBU_1153 | 548 | March 2008 | 1GXB | 10.4% | Coxiella burnetii | |||||||||||||||||||||||
| IDP90089 | 8 | ZZZ_0005 | 600 | Justification:This protein is a component of a type VI secretion system of enter... | Community Requests | Escherichia coli | ||||||||||||||||||||||||
| IDP90163 | 8 | 172044608 | 3-dehydroquinate dehydratase (3-dehydroq... | 255 | Community Requests | 1GQN | 53.3% | Clostridium difficile | ||||||||||||||||||||||
| IDP02782 | 1 | GBAA4874 | 161611196 | fabG | 3-ketoacyl-(acyl-carrier-protein) reduct... | 252 | N/A | June 2008 | 1WMB | 33.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP02395 | 1 | GBAA3321 | 161611191 | serC | phosphoserine aminotransferase [Bacillus... | 324 | N/A | June 2008 | 1W23 | 50% | Bacillus anthracis | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP01493 | 1 | VCA0751 | 161582040 | 3-oxoacyl-(acyl carrier protein) synthas... | 362 | Drug Target Function | March 2008 | 2EBD | 40.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01397 | 1 | VC0755 | 161582019 | aminopeptidase B | 429 | Drug Target Function | March 2008 | 1GYT | 29.8% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01680 | 1 | VC0902 | 161582018 | queF | 7-cyano-7-deazaguanine reductase [Vibrio... | 281 | N/A | June 2008 | 3BP1 | 100% | Vibrio cholerae | N/A | N/A | |||||||||||||||||
| IDP01405 | 1 | VC0905 | 161582017 | lipoprotein YaeC | 269 | Conserved Gene / Pathway | March 2008 | 1P99 | 34.9% | Vibrio cholerae | Cell envelope | Other | ||||||||||||||||||
| IDP01513 | 1 | VC1312 | 161582006 | alr | alanine racemase | 407 | Conserved Gene / Pathway | March 2008 | 1BD0 | 25.3% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01454 | 1 | VC2403 | 161581989 | murD | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 444 | Conserved Gene / Pathway | March 2008 | 1E0D | 51.8% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01459 | 1 | VC2420 | 161581987 | flavodoxin | 172 | Conserved Gene / Pathway | March 2008 | 1AG9 | 45.3% | Vibrio cholerae | Energy metabolism | Electron transport | ||||||||||||||||||
| IDP00476 | 1 | YPO0063 | 161486895 | hypothetical protein YPO0063 | 456 | Virulence Associated Factor | March 2008 | 1I84 | 16.7% | Yersinia pestis | Cell envelope | Other | ||||||||||||||||||
| IDP00591 | 1 | YPO0145 | 161486893 | mrcA | penicillin-binding protein | 859 | Drug Target Function | March 2008 | 2JCH | 21% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00589 | 1 | YPO0954 | 161486886 | mltC | membrane-bound lytic murein transglycosy... | 358 | Drug Target Function | March 2008 | 1QSA | 17.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00401 | 1 | YPO2490 | 161486873 | putative hemolysin | 2531 | Virulence Associated Factor | March 2008 | 1RWR | 3.9% | Yersinia pestis | Viral functions | General | ||||||||||||||||||
| IDP02086 | 1 | YPO3557 | 161486860 | gltB | glutamate synthase subunit alpha [Yersin... | 1538 | N/A | June 2008 | 1EA0 | 45% | Yersinia pestis | Amino acid biosynthesis | Glutamate family | |||||||||||||||||
| IDP00871 | 1 | STM1444 | 161353603 | slyA | transcriptional regulator SlyA | 144 | Drug Target Function | March 2008 | 3DEU | 97.9% | Salmonella typhimurium | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00969 | 1 | STM1597 | 161353598 | ydcW | putative aldehyde dehydrogenase | 474 | Conserved Gene / Pathway | March 2008 | 1WNB | 83.5% | Salmonella typhimurium | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP00867 | 1 | STM3730 | 161353581 | dfp | phosphopantothenoylcysteine synthase/dec... | 406 | Essential Gene | March 2008 | 1U7U | 50.5% | Salmonella typhimurium | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | |||||||||||||||||
| IDP01077 | 1 | STM4122 | 161353577 | argB | acetylglutamate kinase | 257 | Conserved Gene / Pathway | March 2008 | 1GS5 | 94.2% | Salmonella typhimurium | Amino acid biosynthesis | Glutamate family | |||||||||||||||||
| IDP01084 | 1 | STM4377 | 161353573 | aidB | putative acyl-CoA dehydrogenase | 546 | Conserved Gene / Pathway | March 2008 | 3DJL | 84.6% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Degradation | |||||||||||||||||
| IDP01085 | 1 | STM4397 | 161353572 | fklB | FKBP-type 22KD peptidyl-prolyl cis-trans... | 206 | Conserved Gene / Pathway | March 2008 | 1FD9 | 40.3% | Salmonella typhimurium | Protein synthesis | Translation factors | |||||||||||||||||
| IDP00275 | 1 | NP_056776_776-1127 | 159024209 | N/A | NS1 | 352 | N/A | June 2008 | Dengue virus | host defense modulator | N/A | |||||||||||||||||||
| IDP00264 | 1 | NP_056776_2244-2491 | 159024209 | N/A | NS4B | 248 | N/A | June 2008 | Dengue virus | Transcription | N/A | |||||||||||||||||||
| IDP90084 | 8 | ZP_01795673 | 145640079 | 148 | Justification:The protein we would like structure analyzed is from Haemophilus i... | Community Requests | 1KLX | 21.6% | Haemophilus influenzae | |||||||||||||||||||||
| IDP90083 | 8 | ZP_01795671 | 145640077 | 219 | Justification:The protein we would like structure analyzed is from Haemophilus i... | Community Requests | 1OUV | 23.7% | Haemophilus influenzae | |||||||||||||||||||||
| IDP90161 | 8 | 123174273 | Chorismate synthase (5-enolpyruvylshikim... | 359 | Community Requests | 1UM0 | 38.7% | Clostridium difficile | ||||||||||||||||||||||
| IDP90162 | 8 | 123174272 | 3-dehydroquinate synthase | 354 | Community Requests | 1DQS | 37% | Clostridium difficile | ||||||||||||||||||||||
| IDP90165 | 8 | 123174271 | 3-phosphoshikimate 1-carboxyvinyltransfe... | 437 | Community Requests | 1G6S | 31.4% | Clostridium difficile | ||||||||||||||||||||||
| IDP90167 | 8 | 123066836 | Shikimate kinase | 177 | Community Requests | 2PT5 | 31.6% | Clostridium difficile | ||||||||||||||||||||||
| IDP90164 | 8 | 122973876 | Putative chorismate biosynthesis-related... | 337 | Community Requests | 1RZM | 47.2% | Clostridium difficile | ||||||||||||||||||||||
| IDP90166 | 8 | 122379558 | aroE | Shikimate dedydrogenase | 269 | Community Requests | 1NVT | 37.9% | Clostridium difficile | |||||||||||||||||||||
| IDP90081 | 8 | ABD79034.1 | 89892477 | M2 | 96 | Justification:Influenza matrix protein 2 (M2) is a validated therapeutic target ... | Community Requests | 2RLF | 42.7% | Influenza A | ||||||||||||||||||||
| IDP90082 | 8 | P03493.2 | 85681917 | 109 | Justification:Influenza matrix protein 2 (M2) is a validated therapeutic target ... | Community Requests | Influenza B | |||||||||||||||||||||||
| IDP01155 | 1 | BA_0312 | 81837905 | Methionine import ATP-binding protein me... | 339 | Conserved Gene / Pathway | March 2008 | 3DHW | 49.3% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01118 | 1 | BA_4030 | 81837831 | Bifunctional protein pyrR [Includes: Pyr... | 180 | Conserved Gene / Pathway | March 2008 | 1A3C | 73.9% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP01191 | 1 | BA_0882 | 81837776 | Protein translocase subunit secA 2 | 788 | Conserved Gene / Pathway | March 2008 | 1M6N | 48% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | ||||||||||||||||||
| IDP01197 | 1 | BA_1389 | 81715334 | D-alanine--poly(phosphoribitol) ligase s... | 503 | Conserved Gene / Pathway | March 2008 | 3DHV | 99.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00021 | 1 | BA_5529 | 81714862 | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 434 | Drug Target Homolog | October 2007 | 1NAW | 50.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00022 | 1 | BA_5578 | 81714842 | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 429 | Drug Target Homolog | October 2007 | 1EJC | 44.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01186 | 1 | BA_0298 | 81584380 | Bifunctional purine biosynthesis protein... | 511 | Conserved Gene / Pathway | March 2008 | 1ZCZ | 40.1% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP01179 | 1 | BA_0048 | 81583548 | Bifunctional protein glmU [Includes: UDP... | 459 | Drug Target Function | March 2008 | 1G95 | 51.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00017 | 1 | BA_4333 | 81581445 | ribBA | Riboflavin biosynthesis protein ribBA [I... | 397 | Drug Target Homolog | October 2007 | 2BZ0 | 27% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP01218 | 1 | BA_3712 | 73919984 | Histidine ammonia-lyase (Histidase) | 505 | Drug Target Function | March 2008 | 1B8F | 42.2% | Bacillus anthracis | Energy metabolism | Amino acids and amines | ||||||||||||||||||
| IDP90150 | 8 | MPXV_ZAI1979_005_202 | 68449275 | 176 | Justification:similar to CPXV-GRI-C2L, MPXV-ZAI96-N3R | Community Requests | Monkeypox virus | |||||||||||||||||||||||
| IDP90149 | 8 | MPXV_ZAI1979_005_195.5 | 68449268 | serine protease inhibitor-like SPI-1 pro... | 357 | Justification:similar to part of VACV-COP-C12L, MPXV-ZAI96-B19R | Community Requests | 1F0C | 42% | Monkeypox virus | ||||||||||||||||||||
| IDP90148 | 8 | MPXV_ZAI1979_005_195 | 68449267 | serine protease inhibitor-like SPI-1 pro... | 71 | Justification:similar to part of VACV-COP-C12L, MPXV-ZAI96-B19R | Community Requests | Monkeypox virus | ||||||||||||||||||||||
| IDP90147 | 8 | MPXV_ZAI1979_005_194 | 68449266 | kelch-like protein [Monkeypox virus] | 70 | Justification:similar to CPXV-GRI-B19R, MPXV-ZAI96-B18R | Community Requests | 2Q81 | 31.4% | Monkeypox virus | ||||||||||||||||||||
| IDP90146 | 8 | MPXV_ZAI1979_005_193 | 68449265 | ankyrin-like protein [Monkeypox virus] | 789 | Justification:similar to VACV-COP-B20R, MPXV-ZAI96-B17R | Community Requests | 1MJ0 | 5.2% | Monkeypox virus | ||||||||||||||||||||
| IDP90145 | 8 | MPXV_ZAI1979_005_192 | 68449264 | 352 | Justification:similar to VACV-COP-B19R, MPXV-ZAI96-B16R | Community Requests | 1G0Y | 16.5% | Monkeypox virus | |||||||||||||||||||||
| IDP90144 | 8 | MPXV_ZAI1979_005_189.5 | 68449261 | bifunctional IL-1-beta-inhibitor/prevent... | 126 | Justification:contains IG fold, similar to VACV-WR-197, MPXV-ZAR_1979_005-184 | Community Requests | 1G0Y | 27.8% | Monkeypox virus | ||||||||||||||||||||
| IDP90143 | 8 | MPXV_ZAI1979_005_189 | 68449260 | bifunctional IL-1-beta-inhibitor/prevent... | 210 | Justification:contains IG fold, similar to VACV-WR-197, MPXV-ZAR_1979_005-184 | Community Requests | Monkeypox virus | ||||||||||||||||||||||
| IDP90142 | 8 | MPXV_ZAI1979_005_188 | 68449259 | unknown [Monkeypox virus] | 149 | Justification:similar to VACV-COP-B15R, MPXV-ZAI96-B13R | Community Requests | 2VVY | 93.3% | Monkeypox virus | ||||||||||||||||||||
| IDP90141 | 8 | MPXV_ZAI1979_005_186 | 68449257 | ser/thr protein kinase-like protein [Mon... | 282 | Justification:similar to VACV-COP-B12R, MPXV-ZAI96-B11R | Community Requests | 2JII | 30.9% | Monkeypox virus | ||||||||||||||||||||
| IDP90140 | 8 | MPXV_ZAI1979_005_184 | 68449255 | 221 | Justification:similar to VACV-COP-B9R, MPXV-ZAI96-B10R | Community Requests | Monkeypox virus | |||||||||||||||||||||||
| IDP90139 | 8 | MPXV_ZAI1979_005_182 | 68449253 | 182 | Justification:virulence, ER resident, similar to VACV-COP-B7R, N-terminal signal... | Community Requests | Monkeypox virus | |||||||||||||||||||||||
| IDP90138 | 8 | MPXV_ZAI1979_005_181 | 68449252 | ankyrin-like protein [Monkeypox virus] | 119 | Justification:similar to VACV-COP-B6R, MPXV-ZAI96-B7R | Community Requests | Monkeypox virus | ||||||||||||||||||||||
| IDP90137 | 8 | MPXV_ZAI1979_005_179 | 68449250 | ankyrin-like protein [Monkeypox virus] | 561 | Justification:similar to VACV-COP-B4R, MPXV-ZAI96-B5R | Community Requests | 1N11 | 11.2% | Monkeypox virus | ||||||||||||||||||||